Indications for implantable cardioverter defibrillator use for primary prevention of sudden cardiac death

Mithilesh Das, Rajdeep Gaitonde, John Miller

Research output: Contribution to journalArticle

2 Citations (Scopus)

Abstract

The implantable cardioverter defibrillator (ICD) is used for primary and secondary prophylaxis of sudden cardiac death in high-risk patients. Although several trials have demonstrated the superiority of ICD over standard medical therapy or antiarrhythmic medication in this population, a few trials have not shown survival benefit. This review examines the major ICD trials that provide the basis for current therapy in this rapidly changing and very important area of cardiology.

Original languageEnglish
Pages (from-to)371-380
Number of pages10
JournalCurrent Cardiology Reports
Volume9
Issue number5
DOIs
StatePublished - Sep 2007

Fingerprint

Implantable Defibrillators
Sudden Cardiac Death
Primary Prevention
Cardiology
Survival
Therapeutics
Population

ASJC Scopus subject areas

  • Cardiology and Cardiovascular Medicine

Cite this

Indications for implantable cardioverter defibrillator use for primary prevention of sudden cardiac death. / Das, Mithilesh; Gaitonde, Rajdeep; Miller, John.

In: Current Cardiology Reports, Vol. 9, No. 5, 09.2007, p. 371-380.

Research output: Contribution to journalArticle

@article{664fe1901980456d9c491f035f19e296,
title = "Indications for implantable cardioverter defibrillator use for primary prevention of sudden cardiac death",
abstract = "The implantable cardioverter defibrillator (ICD) is used for primary and secondary prophylaxis of sudden cardiac death in high-risk patients. Although several trials have demonstrated the superiority of ICD over standard medical therapy or antiarrhythmic medication in this population, a few trials have not shown survival benefit. This review examines the major ICD trials that provide the basis for current therapy in this rapidly changing and very important area of cardiology.",
author = "Mithilesh Das and Rajdeep Gaitonde and John Miller",
year = "2007",
month = "9",
doi = "10.1007/BF02938364",
language = "English",
volume = "9",
pages = "371--380",
journal = "Current Cardiology Reports",
issn = "1523-3782",
publisher = "Current Medicine Group",
number = "5",

}

TY - JOUR

T1 - Indications for implantable cardioverter defibrillator use for primary prevention of sudden cardiac death

AU - Das, Mithilesh

AU - Gaitonde, Rajdeep

AU - Miller, John

PY - 2007/9

Y1 - 2007/9

N2 - The implantable cardioverter defibrillator (ICD) is used for primary and secondary prophylaxis of sudden cardiac death in high-risk patients. Although several trials have demonstrated the superiority of ICD over standard medical therapy or antiarrhythmic medication in this population, a few trials have not shown survival benefit. This review examines the major ICD trials that provide the basis for current therapy in this rapidly changing and very important area of cardiology.

AB - The implantable cardioverter defibrillator (ICD) is used for primary and secondary prophylaxis of sudden cardiac death in high-risk patients. Although several trials have demonstrated the superiority of ICD over standard medical therapy or antiarrhythmic medication in this population, a few trials have not shown survival benefit. This review examines the major ICD trials that provide the basis for current therapy in this rapidly changing and very important area of cardiology.

UR - http://www.scopus.com/inward/record.url?scp=34548424125&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=34548424125&partnerID=8YFLogxK

U2 - 10.1007/BF02938364

DO - 10.1007/BF02938364

M3 - Article

VL - 9

SP - 371

EP - 380

JO - Current Cardiology Reports

JF - Current Cardiology Reports

SN - 1523-3782

IS - 5

ER -